151 related articles for article (PubMed ID: 10653131)
1. Genetic polymorphism of xenobiotic metabolising enzymes in Slovenian lung cancer patients.
Dolzan V; Rudolf Z; Breskvar K
Pflugers Arch; 2000; 439(3 Suppl):R29-30. PubMed ID: 10653131
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphism of xenobiotic metabolising enzymes in Slovenian lung cancer patients.
Dolžan V; Rudolf Z; Breskvar K
Pflugers Arch; 2000 Jan; 439(Suppl 1):r029-r030. PubMed ID: 28176062
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk.
Gsur A; Haidinger G; Hollaus P; Herbacek I; Madersbacher S; Trieb K; Pridun N; Mohn-Staudner A; Vetter N; Vutuc C; Micksche M
Anticancer Res; 2001; 21(3C):2237-42. PubMed ID: 11501853
[TBL] [Abstract][Full Text] [Related]
4. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility.
Reszka E; Wasowicz W; Gromadzinska J
Br J Nutr; 2006 Oct; 96(4):609-19. PubMed ID: 17010218
[TBL] [Abstract][Full Text] [Related]
6. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
7. Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study.
Raimondi S; Boffetta P; Anttila S; Bröckmoller J; Butkiewicz D; Cascorbi I; Clapper ML; Dragani TA; Garte S; Gsur A; Haidinger G; Hirvonen A; Ingelman-Sundberg M; Kalina I; Lan Q; Leoni VP; Le Marchand L; London SJ; Neri M; Povey AC; Rannug A; Reszka E; Ryberg D; Risch A; Romkes M; Ruano-Ravina A; Schoket B; Spinola M; Sugimura H; Wu X; Taioli E
Mutat Res; 2005 Dec; 592(1-2):45-57. PubMed ID: 16009381
[TBL] [Abstract][Full Text] [Related]
8. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
[TBL] [Abstract][Full Text] [Related]
9. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
10. GST M1 and CYP1A1 gene polymorphism and daily fruit consumption in Turkish patients with non-small cell lung carcinomas.
Oztürk O; Isbir T; Yaylim I; Kocatürk CI; Gürses A
In Vivo; 2003; 17(6):625-32. PubMed ID: 14758730
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
[TBL] [Abstract][Full Text] [Related]
12. Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma.
Lin P; Wang SL; Wang HJ; Chen KW; Lee HS; Tsai KJ; Chen CY; Lee H
Br J Cancer; 2000 Feb; 82(4):852-7. PubMed ID: 10732758
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between CYP1A1, GSTM1 genetic polymorphisms and susceptibility to esophageal squamous cell carcinoma].
Shao G; Su Y; Huang G; Wen B
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):420-3. PubMed ID: 11860825
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between genetic polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer].
Li WY; Lai BT; Zhan XP
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1042-5. PubMed ID: 15769360
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator.
Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB
Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk.
Dialyna IA; Miyakis S; Georgatou N; Spandidos DA
Oncol Rep; 2003; 10(6):1829-35. PubMed ID: 14534704
[TBL] [Abstract][Full Text] [Related]
17. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
[TBL] [Abstract][Full Text] [Related]
18. Evidence for increased cytochrome P450 1A1 expression in blood lymphocytes of lung cancer patients.
Shah PP; Saurabh K; Pant MC; Mathur N; Parmar D
Mutat Res; 2009 Nov; 670(1-2):74-8. PubMed ID: 19632247
[TBL] [Abstract][Full Text] [Related]
19. Structure and polymorphisms of human aryl hydrocarbon receptor repressor (AhRR) gene in a French population: relationship with CYP1A1 inducibility and lung cancer.
Cauchi S; Stücker I; Cénée S; Kremers P; Beaune P; Massaad-Massade L
Pharmacogenetics; 2003 Jun; 13(6):339-47. PubMed ID: 12777964
[TBL] [Abstract][Full Text] [Related]
20. CYP1A1 gene polymorphisms and smoking status as modifier factors for lung cancer risk.
Hussein AG; Pasha HF; El-Shahat HM; Gad DM; Toam MM
Gene; 2014 May; 541(1):26-30. PubMed ID: 24613751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
